Clinical Trials Directory

Trials / Unknown

UnknownNCT05070715

Comparison of Microplastic Levels in Placenta and Cord Blood Samples of Pregnant Women With Fetal Growth Retardation and Healthy Pregnant Women

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Kutahya Health Sciences University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

In this study, microplastic levels in the placenta and cord blood of pregnant women with fetal growth retardation and healthy pregnant women will be compared in placenta and cord blood samples after delivery.

Detailed description

The study will be conducted with a total of 40 pregnant women, 20 of whom are in the control groups and those with FGR diagnoses. Cases in both groups will be matched in terms of demographic information. Demographic information (including socioeconomic status, educational level, region of residence), ultrasound and Doppler examination results, newborn weight at birth, APGAR score, gender, mode of delivery, whether there is a need for neonatal intensive care or not will be recorded.

Conditions

Interventions

TypeNameDescription
OTHERAnalyzing of microplastic levelBlood samples will be taken from the vein of the umbilical cord. Placental tissues will be taken from the maternal side of the placenta. Placental tissues and serum samples will be stored in the temperature set to -80 °C until analysis. Extraction methods involving chemical reactions will be used to separate and purify microplastics in placenta and cord blood samples. After the extraction process, analysis of microplastic levels in tissues and serum will be done by µ-Raman spectroscopy.

Timeline

Start date
2022-03-29
Primary completion
2023-02-26
Completion
2023-03-26
First posted
2021-10-07
Last updated
2022-04-01

Source: ClinicalTrials.gov record NCT05070715. Inclusion in this directory is not an endorsement.